Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03487588 · ClinicalTrials.gov registry record · Phase 4
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
A Phase 4 study, sponsored by Aclaris Therapeutics.
- Completed
- Registry status
- Phase 4
- Development phase
- 41
- Enrollment target
NCT03487588 is a Phase 4 study that has completed, run by Aclaris Therapeutics. The registered enrollment target is 41 participants.
The verdict
NCT03487588, a Phase 4 study, has completed, sponsored by Aclaris Therapeutics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
Interventions
- DRUG A-101 Topical Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-03-21 |
| Est. Completion | 2018-11-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03487588
The ClinicalTrials.gov registry entry for NCT03487588 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aclaris Therapeutics, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which A-101 Topical Solution is the first listed.
NCT03487588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03487588 about?
NCT03487588 is a clinical study titled "An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses". This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
What is the current status of trial NCT03487588?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 41 participants. The study started on 2018-03-21. Estimated completion is 2018-11-14.
What interventions are being tested in trial NCT03487588?
The interventions under investigation include: A-101 Topical Solution (DRUG).
Who is sponsoring clinical trial NCT03487588?
This trial is sponsored by Aclaris Therapeutics, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.